SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Jonathan J. Darrow · Study

Home/Author

Jonathan J. Darrow

6 works· latest 2020· 2 institutionscluster: provisionalORCID 0000-0002-7351-4243

h-index5

i105

Citations881

Works here6

06

14

15

17

18

20

Most cited in this library

FDA Approval and Regulation of Pharmaceuticals, 1983-20182020 · 377 citations
Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study2015 · 189 citations
New FDA Breakthrough-Drug Category — Implications for Patients2014 · 119 citations
Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines2018 · 109 citations
The FDA’s Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-20162017 · 84 citations

Works

6 shown

FDA Approval and Regulation of Pharmaceuticals, 1983-2018

JAMA·2020·3 authors

377citations

Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines

Journal of Clinical Oncology·2018·7 authors

109citations

The FDA’s Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016

JAMA·2017·3 authors·Open access

84citations

Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study

BMJ·2015·4 authors·Open access

189citations

New FDA Breakthrough-Drug Category — Implications for Patients

New England Journal of Medicine·2014·3 authors·Open access

119citations

Employment Termination for Employee Blogging: Number One Tech Trend for 2005 and Beyond, or a Recipe for Getting Dooced?

SSRN Electronic Journal·2006·2 authors·preprint·Open access

3citations